Steve Harvey is gene maker as well as the CEO and founder of Camena Bioscience. Before joining Camena, he was working as a scientist at Wellcome Trust Sanger Institute. He has a background in life sciences technology development, has authored publications in leading scientific journals, including Nature and PLOS Biology, and developed patented DNA synthesis technology.

Steve obtained his PhD from University College London, while working at the National Institute for Medical Research (now the Francis Crick Institute).